Onconic Therapeutics, Inc. (476060) Price & Analysis

― Followers

476060 Stock Chart & Stats

₩14520.00

₩0.00(0.00%)

Aug 24, 2026

―

Day’s Range― - ―

52-Week Range₩5,975.00 - ₩28,900.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)417.22K

Market Cap

₩659.32B

Enterprise Value₩554.24K

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)26.7

Beta0.29

Next Earnings

Nov 17, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)83.12

Shares Outstanding45,407,840

10 Day Avg. Volume758,218

30 Day Avg. Volume417,222

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

476060 FAQ

What was Onconic Therapeutics, Inc.’s price range in the past 12 months?

Onconic Therapeutics, Inc. lowest stock price was ₩5975.00 and its highest was ₩28900.00 in the past 12 months.

What is Onconic Therapeutics, Inc.’s market cap?

Onconic Therapeutics, Inc.’s market cap is ₩659.32B.

When is Onconic Therapeutics, Inc.’s upcoming earnings report date?

Onconic Therapeutics, Inc.’s upcoming earnings report date is Nov 17, 2026 which is in 84 days.

How were Onconic Therapeutics, Inc.’s earnings last quarter?

Onconic Therapeutics, Inc. released its earnings results on Aug 12, 2026. The company reported ₩83.117 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Onconic Therapeutics, Inc. overvalued?

According to Wall Street analysts Onconic Therapeutics, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Onconic Therapeutics, Inc. pay dividends?

Onconic Therapeutics, Inc. does not currently pay dividends.

What is Onconic Therapeutics, Inc.’s EPS estimate?

Onconic Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Onconic Therapeutics, Inc. have?

Onconic Therapeutics, Inc. has 45,407,840 shares outstanding.

What happened to Onconic Therapeutics, Inc.’s price movement after its last earnings report?

Onconic Therapeutics, Inc. reported an EPS of ₩83.117 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6.397%.

Which hedge fund is a major shareholder of Onconic Therapeutics, Inc.?

Currently, no hedge funds are holding shares in KR:476060

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology